The previous result shows that it was highly expressed in HCC cell lines, clinical HCC tissues, and poor survival in HCC patients, and URHC high expression promoted tumor growth and inhibited apoptosis via ERK/MAPK inactivation by targeting ZAK [33]. The gene discussed is MAP3K20; the disease is hepatocellular carcinoma.